303 related articles for article (PubMed ID: 28532539)
1. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
[TBL] [Abstract][Full Text] [Related]
2. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
Wang L; Tang C; Xu B; Yang L; Qu L; Li L; Li X; Wang W; Qin H; Gao H; He K; Liu X
PLoS One; 2017; 12(6):e0179000. PubMed ID: 28594947
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary study of MALDI-TOF mass spectrometry-based screening of patients with the NSCLC serum-specific peptides].
An J; Tang C; Wang N; Liu Y; Guo W; Li X; Wang Z; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):233-9. PubMed ID: 23676979
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate molecular markers predicting chemotherapy resistance in non-small cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
Clin Chem Lab Med; 2010 Jun; 48(6):863-7. PubMed ID: 20345233
[TBL] [Abstract][Full Text] [Related]
6. Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.
Rovithi M; Lind JS; Pham TV; Voortman J; Knol JC; Verheul HM; Smit EF; Jimenez CR
Proteomics Clin Appl; 2016 Jul; 10(7):743-9. PubMed ID: 27040893
[TBL] [Abstract][Full Text] [Related]
7. Detection of lung cancer using plasma protein profiling by matrix-assisted laser desorption/ionization mass spectrometry.
Shevchenko VE; Arnotskaya NE; Zaridze DG
Eur J Mass Spectrom (Chichester); 2010; 16(4):539-49. PubMed ID: 20625202
[TBL] [Abstract][Full Text] [Related]
8. Support vector machines coupled with proteomics approaches for detecting biomarkers predicting chemotherapy resistance in small cell lung cancer.
Han M; Dai J; Zhang Y; Lin Q; Jiang M; Xu X; Liu Q; Jia J
Oncol Rep; 2012 Dec; 28(6):2233-8. PubMed ID: 22992788
[TBL] [Abstract][Full Text] [Related]
9. The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
Xu J; Xu B; Tang C; Li X; Qin H; Wang W; Wang H; Wang Z; Li L; Li Z; Gao H; He K; Liu X
Dis Markers; 2017; 2017():3160426. PubMed ID: 28386154
[No Abstract] [Full Text] [Related]
10. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
Lin XL; Yang SY; Du J; Tian YX; Bu LN; Huo SF; Wang FP; Nan YD
Chin Med J (Engl); 2010 Jan; 123(1):34-9. PubMed ID: 20137572
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
[TBL] [Abstract][Full Text] [Related]
12. Serum peptidome profiling in patients with lung cancer.
Yang J; Yang SY; Hu XY; Huo SF; Shang WL; Li ZF; Ni L; Wang AY; Guo YM; Song TS; Chen-Huang
Anat Rec (Hoboken); 2010 Dec; 293(12):2027-33. PubMed ID: 21082738
[TBL] [Abstract][Full Text] [Related]
13. [Preliminary Study of Differentially Expressed Serum Peptides of Advanced NSCLC Patients Responsive to EGFR-TKI and Their Clinical Significance].
Wang Z; Tang C; Liu Y; Xu B; Qin H; Lei Y; Gao H; He K; Liu X
Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):600-6. PubMed ID: 27666550
[TBL] [Abstract][Full Text] [Related]
14. Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies.
Labots M; Schütte LM; van der Mijn JC; Pham TV; Jiménez CR; Verheul HM
Oncologist; 2014 Oct; 19(10):1028-39. PubMed ID: 25187478
[TBL] [Abstract][Full Text] [Related]
15. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
16. Proteomic identification of predictive tissue biomarkers of sensitive to neoadjuvant chemotherapy in squamous cervical cancer.
Guo L; Zhang C; Zhu J; Yang Y; Lan J; Su G; Xie X
Life Sci; 2016 Apr; 151():102-108. PubMed ID: 26947588
[TBL] [Abstract][Full Text] [Related]
17. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum-paclitaxel chemotherapy.
Li Z; Qing Y; Guan W; Li M; Peng Y; Zhang S; Xiong Y; Wang D
Cancer Chemother Pharmacol; 2014 Oct; 74(4):777-86. PubMed ID: 25107571
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy.
Grossi F; Genova C; Rijavec E; Barletta G; Biello F; Dal Bello MG; Meyer K; Roder J; Roder H; Grigorieva J
Lung Cancer; 2018 Mar; 117():64-69. PubMed ID: 29395121
[TBL] [Abstract][Full Text] [Related]
20. Comparison of peptide cancer signatures identified by mass spectrometry in serum of patients with head and neck, lung and colorectal cancers: association with tumor progression.
Pietrowska M; Polańska J; Suwiński R; Wideł M; Rutkowski T; Marczyk M; Domińczyk I; Ponge L; Marczak L; Polański A; Widłak P
Int J Oncol; 2012 Jan; 40(1):148-56. PubMed ID: 21894432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
